
Sign up to save your podcasts
Or


The Justice Department's move to reclassify medical marijuana from a Schedule I to a Schedule III drug marks a major federal policy shift with potential ripple effects in Texas. Dylan McKim breaks down what the change means for research and public health, what stays the same, and why some experts warn the move opens the door to profit‑driven expansion without enough safeguards.
By KXAN News5
66 ratings
The Justice Department's move to reclassify medical marijuana from a Schedule I to a Schedule III drug marks a major federal policy shift with potential ripple effects in Texas. Dylan McKim breaks down what the change means for research and public health, what stays the same, and why some experts warn the move opens the door to profit‑driven expansion without enough safeguards.

11,053 Listeners

374 Listeners

56,636 Listeners

5,207 Listeners

172 Listeners

6,401 Listeners

58,222 Listeners

39,551 Listeners

26,634 Listeners

3,394 Listeners

19,751 Listeners